IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.3880
-0.0060 (-1.52%)
Sep 25, 2026, 3:34 PM CET
IDL Diagnostics AB Market Cap
IDL Diagnostics AB has a market cap or net worth of 89.38 million as of September 25, 2026. Its market cap has decreased by -3.00% in one year.
Market Cap
89.38M
Enterprise Value
66.22M
Revenue
58.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
ChartMarket Cap Chart
Since May 25, 2011, IDL Diagnostics AB's market cap has increased from 16.78M to 89.38M, an increase of 432.73%. That is a compound annual growth rate of 11.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 89.38M | 9.92% |
| Dec 30, 2025 | 81.32M | -9.49% |
| Dec 30, 2024 | 89.84M | -10.76% |
| Dec 29, 2023 | 100.67M | -29.52% |
| Dec 30, 2022 | 142.82M | 31.17% |
| Dec 30, 2021 | 108.88M | -38.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 155.98B |
| Getinge AB | 66.87B |
| Sectra AB | 53.68B |
| Medicover AB | 38.98B |
| Biovica International AB | 92.24M |
| Boule Diagnostics AB | 92.03M |
| Immunovia AB | 91.89M |
| Ascelia Pharma AB | 82.79M |